<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638336</url>
  </required_header>
  <id_info>
    <org_study_id>IDIL/2016/SD-01</org_study_id>
    <nct_id>NCT03638336</nct_id>
  </id_info>
  <brief_title>Evaluation of the Performance of a Robotic Flexible Ureteroscopy (ILY) in Laser Treatment of Nephrolithiasis</brief_title>
  <acronym>EASILY</acronym>
  <official_title>Evaluation of the Performance of a Robotic Flexible Ureteroscopy (ILY) in Laser Treatment of Nephrolithiasis in the Upper Urinary Tract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this pilot study, we wish to evaluate the performance of a robotic flexible ureteorscopy
      (ILY) in the treatment of nephrolithiasis in the superior excretory system
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2018</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of procedures performed entirely using the telemanipulator</measure>
    <time_frame>end of study: 3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of procedures where the surgeon had to switch to manual mode or dedock the device</measure>
    <time_frame>end of study: 3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>If telemanipulator remained stable during procedure</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>Yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of procedure</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Docking time</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>time between docking of device and use of gamepad</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time taken to track kidney stones</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time taken for complete exploration of renal cavities</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Laser fragmentation time</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Speed of fragmentation</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>mm3/minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Any joint pain strain experienced by the surgeon before and after intervention</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>binary yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction of surgeon in using the device</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>Custom-made questionnaire with 3 sections measuring: ease of use, ergonomics in exploration of renal cavities and stability during fragmentation of laser</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe the rate of intra-operative complications during procedure</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Describe the rate of intra-operative complications</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Integrity of the ureroscope at the end of the procedure</measure>
    <time_frame>end of procedure; less than 2 hours</time_frame>
    <description>binary yes/no</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Lithiasis, Urinary</condition>
  <arm_group>
    <arm_group_label>flexible ureteroscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ILY robotic flexible ureteroscopy</intervention_name>
    <description>fragmentation of nephrolithiasis</description>
    <arm_group_label>flexible ureteroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given their free and informed consent and signed the consent
             form

          -  The patient must be a member or beneficiary of a health insurance plan

          -  The patient is at least 18 years old

          -  The patient has a single kidney stone in the calyx or the pelvis between 5 and 15mm
             something to do with a JJ probe

          -  Patient has an indication for in situ lithotripsy by supply ureteroscopy

        Exclusion Criteria:

          -  The subject is participating in an interventional study, or is in a period of
             exclusion determined by a previous study

          -  The patient is under safeguard of justice or state guardianship

          -  The subject refuses to sign the consent

          -  It is impossible to give the subject informed information

          -  The patient is pregnant or breastfeeding

          -  Patient treated with anticoagulants

          -  Documented untreated urinary infection within the previous 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Droupy</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphane Droupy</last_name>
    <phone>04.66.68.30.57</phone>
    <email>stephane.droupy@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Stéphane Droupy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Armand Chevrot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kamel Ben Naoum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 16, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>August 17, 2018</last_update_submitted>
  <last_update_submitted_qc>August 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Lithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

